4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc. (FDMT) is a publicly traded company in the Unknown sector. Across all available filings, 15 corporate insiders have executed 133 transactions totaling $75.3M, demonstrating a bullish sentiment with $26.9M in net insider flow. The most recent transaction on Jan 5, 2026 involved a transaction of 45,000 shares valued at $0.
FDMT Insider Activity Summary
Who Is Buying FDMT Stock?
No significant insider buying has been recorded for FDMT in the recent period.
Who Is Selling FDMT Stock?
No significant insider selling has been recorded for FDMT in the recent period.
Is 4D Molecular Therapeutics Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for FDMT is bullish with an Insider Alignment Score of 68/100 and a net flow of $26.9M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
FDMT Frequently Asked Questions
Understanding FDMT Insider Activity
Insider trading at 4D Molecular Therapeutics Inc. (FDMT) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 15 insiders are actively trading FDMT stock, having executed 133 transactions in the past 90 days. The most active insider is David C. Ott (Executive), who has made 3 transactions totaling $25.3M.
Related Tools
Track 4D Molecular Therapeutics Inc. Insider Activity
Get notified when executives and directors at FDMT file new Form 4 transactions